https://www.selleckchem.com/pr....oducts/bromopyruvic-
86, which was higher than that of TNM stage 0.685 (95% CI = 0.605-0.765). In addition, decision curve analysis also showed the nomogram model had improved predictive accuracy and discriminatory performance for OS, compared to the TNM stage. According to the prognostic model risk score, patients in the high-risk subgroup had a lower 5-year OS rate than that in a low-risk subgroup (23% vs 49%, P less then .0001). Conclusions The nomogram model based on clinicopathological features inflammation- and nutrition-related indicato
Like
Comment
Share
